Get started
PfizerPfizerPfizer

Pfizer

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Options Bonds

PFE trade ideas

Pfizer Inc. (PFE)Shares in makers of vaccine for Covid-19 down after officials including US President Biden called for vaccine IP waivers. This is a dangerous breach in R&D and patents. Who will produce the next vaccine or life-saving drug? First-Quarter 2021 Revenues of $14.6 Billion, Reflecting 42% Operational Growth; Excluding Revenues for BNT162b2 of $3.5 Billion, Revenues Grew 8% Operationally Including a Negative 5% Impact from Pricing ▪ First-Quarter 2021 Reported Diluted EPS(1) of $0.86, Adjusted Diluted EPS(2) of $0.93 ▪ Raises Full-Year 2021 Guidance(3) for Revenues to a Range of $70.5 to $72.5 Billion and Adjusted Diluted EPS(2) to a Range of $3.55 to $3.65
NYSE:PFELong
by mgiuliani
3
$PFE PullbackPrice action looking likely to pull back as there is disequilibrium between the conversion line and the base line on the daily timeframe. This means the price should move down to the base line (Slow MA) bringing the conversion line (Fast MA) with it. furthermore, price moved away from the conversion line creating disequilibrium, and started pulling back on the 22nd of April. I believe the price will continue down before a potential continuation of an uptrend. I am a beginner with the Ichimoku strategies, but I have seen using the indicator in relation to price action that this is a possible outcome before $PFE returning to its uptrend as shown by the bullish Ichimoku cloud. Is anyone able to give tips/advice?
NYSE:PFE
by navshxrir9
3
$PFE - 3rd shot's the charm!On the 1HR timeframe, the MACD is curling down suggests we may be going down before we go up again. RSI also shows it is overbought. I am not the best at EW but this is what I got. Looks like we just finished wave (5) and getting ready for the correction phase. $JNJ has earnings before market open tomorrow and may see PFE sympathy play from them depending which direction they go. PFE looks like it wants to head higher but all the technicals are suggesting otherwise. I already scaled into some puts but I wouldn't be surprised if we gap up to $39 area before coming back down. Let me know what you think!
NYSE:PFEShort
by DarthTrador
4
Pfizer potential multibaggerPfizer share price has always hovering around $34 for a few years, with a recent news of its launch of covid vaccine, price has shot up and people has been selling on new and price has declined since then. Fundamentally, we do expect to report better figure in the next 6 months time and prices will spike on every report. Pfizer being a healthcare stocks, they tend to be the last mover after all the sectors have moved up in a market cycle. Based on its pattern, once broken $44, we will expect the price to scale a all time high at $75 and beyond.
NYSE:PFELong
by 100dollar
4
🔹$PFE 4H Technical Analysis PT 37.28🔸 $PFE 4H Cup & Handle Breakout. This is a **SOLID** setup for this week. I am looking at a 2 week swing for $PFE price target 37.28 on that solid gap fill. Now, the chart looks absolutely beautiful not only that but we have a catalyst play $PFE. We have the PDUFA date on April 28th. I am expecting a run up for that event as well as to fill the gap to the upside. 🔸 Swing* 36.50c 4/30 ( Looking To Get @ Open ) Really Cheap also looking to sell before the event or until we hit our price target on that gap.
NYSE:PFELong
by Firecycle114
1
PFE investing ideaHi my dear subscribers. Today I want to talk about PFE. Everyone know about their products in medicine and COVID-19 vaccine. Why do I think about investing even on not short-term speculation, but for long time. Reasons are: + Growth of Research and Development + Using short and long term investing for diversing of risks + Decreasing of inventories + Really good financial profit results (net margin - 22,94%) + Company pays dividends on 4,2% level + Stock buyback ratio is 2,4% (for 3 years), that means, that Pfizer is strong enough in her business Maybe some moments can cause you be carefull, like growning of long-term debts. At my opinion reason is in the industry of Pfizer. Creating of medicine needs to have big Research and Development costs, with all of this tests, certificates from goverment and so on. That is why I don't think, that big debts level is not so critical (surely, it is still have influence).
NYSE:PFELong
by ValueInvest_Pro